+86-29-89182091
seplite@sunresin.com

Sunresin and ChromaGenix Partner to Expand Global Access to AAV Purification Technologies

AAV purification is one of the most demanding challenges in cell and gene therapy manufacturing. Each serotype behaves differently. Each program comes with its own recovery requirements, impurity profile and scale-up considerations. And for many developers, redesigning the downstream process every time they work with a new serotype adds time, cost and complexity they cannot afford.
 
That is the problem Sunresin and ChromaGenix set out to address together.
 
The two companies have announced a cooperation agreement to support cell and gene therapy developers with advanced chromatography technologies for AAV purification across Asia, Europe and the Americas.
 
Under the agreement, Sunresin will supply and support the resins across Asian markets, while ChromaGenix will continue to serve customers in Europe and the Americas.
 
Why This Collaboration Matters
AAV manufacturing has a well-known bottleneck. Most capture technologies are serotype-specific, which means every new vector candidate can require a completely new downstream strategy. That adds process development time, increases validation complexity and makes it harder to build manufacturing platforms that work across a pipeline.
 
The collaboration between Sunresin and ChromaGenix is designed to change that.
 
AvXcel is designed for serotype-agnostic capture of AAV1-9, rh10, select engineered serotypes and novel capsids. Its synthetic ligand design offers practical process advantages, including near-neutral elution conditions that can improve functional recovery, reduce immediate neutralization requirements and shorten time-in-facility compared with more acidic elution workflows.
 
The collaboration also includes two novel resins developed for the selective removal of host cell proteins and DNA from viral vector and antibody process streams. Together, these technologies address two critical needs in downstream processing: AAV capture and impurity removal.
 
Bringing Technology Closer to Customers
Access to purification technology is only part of the challenge. Cell and gene therapy developers also need technical discussion, regional support and practical guidance when evaluating new chromatography solutions in their own processes.
 
Under the agreement, Sunresin will supply and support the resins across Asian markets, while ChromaGenix will continue to serve customers in Europe and the Americas.
 
This regional structure is intended to help customers access the technologies more easily, discuss process needs locally and receive support during evaluation and implementation.
 
“Cell and gene therapy developers need purification technologies that are technically robust, scalable and easier to apply across different AAV programs,” said Fred Ghanem, Vice President of the Life Science Division at Sunresin. “Our cooperation with ChromaGenix combines complementary strengths: ChromaGenix’s synthetic ligand-based purification technologies and Sunresin’s expertise in chromatography development, manufacturing, supply reliability and customer support across Asia. It gives customers access to a practical platform for both AAV capture and impurity removal.”
 
 
 
Chris Major, CEO of ChromaGenix, also highlighted the importance of broad serotype coverage and synthetic ligand design for downstream development.
 
“Broad serotype coverage can simplify downstream development and reduce the need to redesign the capture step for every new AAV candidate,” said Chris Major. “AvXcel’s synthetic ligand design also offers developers unique process options, including near-neutral elution conditions that can improve functional recovery, reduce immediate neutralization requirements and shorten time-in-facility compared with more acidic elution workflows.”
 
 
Supporting the Future of AAV Manufacturing
The cell and gene therapy field continues to move toward more diverse viral vector pipelines, more demanding quality expectations and stronger pressure to improve manufacturing efficiency.
 
For AAV developers, downstream purification remains one of the areas where better tools can have a direct impact on recovery, impurity clearance, process consistency and scalability.
 
By combining serotype-agnostic affinity capture, selective impurity removal, resin manufacturing capabilities and regional customer support, Sunresin and ChromaGenix aim to help customers build cleaner, more scalable and more consistent AAV manufacturing processes.
 
This cooperation reflects a shared goal: to make advanced AAV purification technologies more accessible to the teams developing the next generation of cell and gene therapies.
 
  Free Quote

Contact Us

Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com seplite_europe@sunresin.com +86-29-89182091
CONTACT US
Our Product List
Amino Acid Separation and Purification
test
Mobile Sorption Module for Gold Extraction
PFAS Removal
Bio-Pharmaceutical & Life Science
Modern biopharmaceutical technologies typically use biological microbial fermentation...
Chemical Industry
Purification of chemical compounds has become a vital part of most industrial processes.
Drinking Water Treatment
Drinking water is essential to life. Every day every human being has to drink and use water for food preparation.
Food & Beverage Industries
Food is closely related to everyone, and the finishing of food comes from people's relentless pursuit...
Hydrometallurgy & Mining
Hydrometallurgy is a technique for extractive metallugry involving the three general area...
Direct Lithium Extraction (DLE)
Sunresin is the major DLE lithium sorbent producer in China which mainly used for extraction lithium from salar brine and geothermal brine etc with high efficiency.
Industry Water Treatment
There are many uses of water in industry and, in most cases, the used water also needs treatment to render...
Plant Extraction
Plant Extraction is a process to gather the trace bioactive compounds from the tissue of a plant.
VOCs Treatment
With the widespread use of chemical products in the industry, more and more organic...
Wastewater Treatment
Wastewater treatment is the process of converting wastewater into an effluent that can be discharged
Latest News
14
2026 07
 Sunresin and ChromaGenix Partner to Expand Global Access to AAV Purification Technologies
The cooperation is designed to expand access to advanced AAV purification technologies and provide stronger regional support for cell and gene therapy developers across Asia, Europe and the Americas.
26
2026 05
 Sunresin Completes Strategic Investment in FENGXINZE to Further Expand Industrial Chromatography Business
Sunresin recently completed a strategic investment in FENGXINZE, further expanding its business footprint in industrial chromatography and strengthening its presence in the life science separation and purification sector.
13
2026 05
 Sunresin Showcases Global Environmental Solutions at IFAT Munich 2026
IFAT Munich 2026 marked Sunresin’s largest overseas exhibition of the year. The company unveiled a newly designed custom-built booth featuring a modern, open, and international design concept, comprehensively showcasing its technologies and application solutions in environmental protection and resource recovery.

Leave a Message

Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit
Here to Provide Complete Separation and Purification Solutions
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
Call us on:
+86-29-89182091
+86-29-89182091
seplite@sunresin.com